dehydroepiandrosterone has been researched along with phosphorylcholine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradlow, HL; Byrne, JJ | 1 |
| Cheng, ML; Chiu, DT; Ho, HY; Shiao, MS; Tang, HY; Weng, SF | 1 |
2 other study(ies) available for dehydroepiandrosterone and phosphorylcholine
| Article | Year |
|---|---|
DHEA-PC slows the progression of type 2 diabetes (non-insulin-dependent diabetes mellitus) in the ZDF/Gmi-fa/fa rat.
Topics: Animals; Blood Glucose; Dehydroepiandrosterone; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Combinations; Glucose Tolerance Test; Male; Obesity; Phosphorylcholine; Rats; Rats, Zucker; Triglycerides | 2001 |
Biochemical disorders associated with antiproliferative effect of dehydroepiandrosterone in hepatoma cells as revealed by LC-based metabolomics.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Chromatography, Liquid; Dehydroepiandrosterone; Glucosephosphate Dehydrogenase; Humans; Liver Neoplasms; Metabolome; Methionine Adenosyltransferase; Mitochondria; Oxidative Stress; Phosphatidylcholines; Phosphorylcholine; S-Adenosylmethionine | 2011 |